KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Amortization of Goodwill (2023)

Historic Amortization of Goodwill for Nektar Therapeutics (NKTR) over the last 1 years, with Q1 2023 value amounting to $76.5 million.

  • Nektar Therapeutics' Amortization of Goodwill changed N/A to $76.5 million in Q1 2023 from the same period last year, while for Dec 2023 it was $76.5 million, marking a year-over-year change of. This contributed to the annual value of $76.5 million for FY2023, which is N/A changed from last year.
  • Nektar Therapeutics' Amortization of Goodwill amounted to $76.5 million in Q1 2023.
  • In the past 5 years, Nektar Therapeutics' Amortization of Goodwill registered a high of $76.5 million during Q1 2023, and its lowest value of $76.5 million during Q1 2023.